Pfizer, Inc. Press Releases

Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma (NHL) Due to Futility
05/20/2013 5:01PM - Business Wire

Pfizer Announces 11 Abstracts for Tofacitinib to Be Presented at the European League Against Rheumatism (EULAR) 2013 Annual Meeting
05/13/2013 8:00AM - Business Wire

Pain Therapeutics Files Form 8-K Regarding Correspondence From Pfizer, Inc.
05/10/2013 6:00AM - GlobeNewswire

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
05/08/2013 4:00PM - Business Wire

Accelrys and Pfizer Extend Agreement for Global Deployment of Scientific Innovation Lifecycle Management Software
05/07/2013 8:00AM - PR Newswire

Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation
05/06/2013 5:00PM - Business Wire

New York Parents Charge Pfizer Actively Concealed True Risks Of Birth Defects To Infants From Zoloft When Prescribed To Mothers During Pregnancy
05/06/2013 3:06PM - Business Wire

Facing Off Against Counterfeit Online Pharmacies: Pfizer Launches New Purchasing Website To Help Alleviate the Guesswork Around Buying Legitimate Viagra® (sildenafil citrate) Online
05/06/2013 8:00AM - Business Wire

Pfizer Reports First-Quarter 2013 Results
04/30/2013 7:00AM - Business Wire

Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes
04/29/2013 7:30AM - Business Wire

Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevenar 13 In Adults Aged 18 To 49 Years
04/28/2013 7:30AM - Business Wire

Pfizer Receives CHMP Negative Opinion Regarding Marketing Authorization In Europe For Rheumatoid Arthritis Treatment XELJANZ® (tofacitinib citrate)
04/25/2013 4:01PM - Business Wire

Pfizer Hosts Annual Meeting Of Shareholders
04/25/2013 11:46AM - Business Wire

Top-Line Data Show Celecoxib Met Primary Objective In Clinical Trial To Evaluate The Effects On Blood Pressure In Pediatric Patients With Juvenile Idiopathic Arthritis
04/25/2013 8:00AM - Business Wire

Pain Therapeutics Reports Q1 2013 Financial Results
04/24/2013 9:00AM - GlobeNewswire

Pfizer Invites Public To Listen To Webcast Of April 25 Annual Meeting Of Shareholders
04/18/2013 1:00PM - Business Wire

GlycoMimetics Announces Top Line Results from Phase 2 Trial with GMI-1070 in Sickle Cell Disease
04/16/2013 6:00AM - Business Wire

Nodality, Inc. Announces Data Presentations at AACR 2013 Annual Meeting
04/11/2013 7:30AM - Business Wire

Pfizer’s Palbociclib (PD-0332991) Receives Food And Drug Administration Breakthrough Therapy Designation For Potential Treatment Of Patients With Breast Cancer
04/10/2013 8:00AM - Business Wire

Nodality, Inc. Announces Expansion of Company’s Patent Estate Covering Programs to Improve the Treatment of Patients with Severe Diseases in Immunology, Oncology, and Autoimmune Diseases
04/09/2013 3:00PM - Business Wire

Acura Pharmaceuticals Awarded U.S. Patent for Abuse Deterrent Drug Formulations
04/04/2013 4:15PM - Market Wire

Advil® Launches Advil® Relief in Action Campaign Celebrating Active Volunteers Who Don’t Let Pain Hold Them Back
04/04/2013 9:00AM - Business Wire

Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures
04/04/2013 8:50AM - PR Newswire

Tetragenetics Announces New Collaboration in SionX™ Technology
04/03/2013 9:00AM - Business Wire

Before the Crowd, How We Found PFE, V, HUM and UNH
04/02/2013 8:00AM - Market Wire